Serum leptin concentration and anaerobic performance do not change during the menstrual cycle of young females

Selcuk University, Meram Faculty of Medicine, Department of Physiology, Konya, Turkey.
Neuro endocrinology letters (Impact Factor: 0.8). 09/2005; 26(4):297-300.
Source: PubMed


It was aimed to determine whether there was a difference in the leptin levels and short term exercise performance during the menstrual cycle of the young females who had normal menstrual cycle and no pregnancy story.
Fifteen sedentary females aged 19-23 yrs were included. All had regular menstrual cycle of 28-30 days and no pregnancy story. Blood samples were taken for the analysis of serum estradiol, progesterone and leptin levels and Wingate test was applied on a Monark 818E ergometer with 75 g/kg load on the 7th, 14th and 21st cycle days, randomly.
The differences in serum leptin levels and peak power, mean power and fatigue index during these days and the correlations between serum leptin and FSH, LH, estradiol and progesterone levels were not significant.
We concluded that performance in a short intense exercise which require high motivation is not affected by menstrual cycle and in young females with normal menstrual cycle, serum leptin concentration does not change during the cycle. Further studies constituting more standard groups, controlling food intake, timing the blood sampling, studying more days of menstrual cycle will help to obtain more accurate results.

Download full-text


Available from: Abdulkerim Kasim Baltaci, Mar 10, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess safety of combined low-dose oral contraceptives in women after renal transplantation. Twenty six female renal graft-recipients, aged from 18 to 44 (mean 31 years), who used combined low-dose oral contraceptives after renal transplantation for at least 18 months were enrolled in the study. All patients had stable graft function with mean serum creatinine of 1.3 mg/dl. In 58% of women effective contraception was the mean indication for the therapy, in the remaining group pills were indicated additionally for the development of ovarian cysts and excessive menstrual bleedings. Ethinyl estradiol dose was 20 mug in 73% of cases and 30-35 microg in the remaining group. No case of pregnancy was observed. Contraceptive therapy was discontinued in two cases: for profound vein thrombosis in one and deterioration of liver function in the other case. No side effects of contraceptives were observed in the remaining group of patients within at least 18-month observational period. No case of ovarian cyst was reported. Oral contraceptives were not found to influence body mass index (BMI), mean blood pressure, serum creatinine and biochemical parameters (AST, ALT, total bilirubin, glucose and cholesterol). Despite the presence of relative contraindications for hormonal drugs (arterial hypertension and deteriorated liver function) in female renal recipients, administration of combined low-dose contraceptive pill should be taken into account as highly effective contraceptive method, that additionally regulates menstrual bleeding patterns, protects from ovarian cysts development and improves life quality of the patient.
    Neuro endocrinology letters 11/2006; 27(5):679-82. · 0.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Leptin is the endocrine product of the LEP gene, which in addition to influencing satiety and energy metabolism, is associated with puberty onset, fertility, and pregnancy. Therefore, second only to its association with obesity, leptin’s role as a reproductive regulator represents the primary research focus of the scientific community to date. A correlation with adipose mass is at least partly responsible for serum leptin concentrations being higher in females than in males, but as maternal levels in pregnancy are greater still, regulatory mechanisms linked to the steroid hormones are strongly suggested. In this regard, leptin levels may directly influence testicular steroidogenesis and be linked to testis development. These mechanisms are further evidenced by animal and in vitro studies that demonstrate a stimulatory influence of estrogen on leptin synthesis, as well as an inhibitory influence of androgens. An association with gonadotropins demonstrates a role for leptin at the hypothalamic level in controlling menstrual cyclicity and ovarian function. Results of clinical reports in humans, in vitro experience employing human tissues, and interventional studies utilizing rodent and nonhuman primate models, have demonstrated a number of roles for the polypeptide, acting through both membrane-bound and soluble forms of its receptor, with respect to implantation, placental function, conceptus growth, and fetal development. Further associations with intrauterine growth restriction, preeclampsia, pregnancy-associated diabetes, and the fetal origin of adult diseases help to place leptin in the forefront of research in reproductive biology.
    12/2006: pages 149-182;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To explore the status of serum leptin levels in various phases of menstrual cycle in females of child bearing age. Methods This observational study was carried out at ShifaCollege of Medicine, Islamabad in which serumleptin level of 83 females of reproductive age invarious phases of female monthly cycle was measured, after taking an informed written consent.ResultsMean serum leptin level of women during follicular phase was 54.6±33.4 ng/ml and luteal phase 53.5±38.8 ng/ml as assessed from last menstrual period (p=0.253). Serum Leptin level was found to be significantly higher in normal weight womenduring follicular phase (37.3±24.8 ng/ml) as compared to normal weight women in luteal phase (24.5±14.3 ng/ml) with p value 0.040. In overweight females, no significant difference wasfound between serum leptin level during follicularphase (78.84±29.07 ng/ml) and luteal phase (81.4±34.2 ng/ml), with p value 0.369. Conclusion We found no significant change in serum leptin level during follicular and luteal phases of menstrual cycles in healthy females. (Rawal Med J 2009;34: 180-182).
    Rawal Medical Journal 07/2009; 34(2).
Show more